Navigation Links
Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc.
Date:6/23/2011

CRANBURY, N.J., June 23, 2011 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) announced today that Alan W. Dunton, M.D., formally joined Palatin's Board of Directors on June 22, 2011 as an independent director and member of Palatin's Audit and Compensation Committees.

"Dr. Dunton brings Palatin both substantial drug development experience and clinical research experience," said Carl Spana, Ph.D., Palatin's CEO.  "He has played a key role in the development of more than 20 products to regulatory approval.  We look forward to working with him as a member of our Board of Directors."

Dr. Dunton is president and principal of Danerius, LLC, a consulting company he founded in 2006. From January 2007 to March 2009, Dr. Dunton served as president and chief executive officer of Panacos Pharmaceuticals Inc. and as a managing director of Panacos from March 2009 to January 2011. Previously he was the President and Chief Executive Officer of Metaphore Pharmaceuticals, Inc. and as President and Chief Operating Officer of Emisphere Technologies, Inc. From 1994 to 2001, Dr. Dunton was a senior executive in various capacities in the Pharmaceuticals Group of Johnson & Johnson, including President and Managing Director of The Janssen Research Foundation.  Dr. Dunton is a member of the board of directors of the publicly-traded companies Targacept, Inc. and Oragenics, Inc.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company focused on developing targeted, receptor-specific small molecule and peptide therapeutics.  Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin Technologies' website at http://www.palatin.com.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PreXion, Inc. Names Visionary Industry Leader, Motoaki Saito, M.D., Ph.D. as CEO
2. David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly
3. Cara Therapeutics Announces Appointment of James B. Jones, M.D., Pharm.D., as Chief Medical Officer
4. iTherX Appoints Stefan Zeuzem, M.D., as Chair of Scientific and Clinical Advisory Board
5. Adeona Appoints George J. Brewer, M.D., Senior Vice President of Research & Development
6. Adeona Mourns the Passing of David A. Newsome, M.D., Senior Vice President of Research & Development
7. Boston Scientific Establishes Endowment for Donald S. Baim, M.D., Scholarship at Yale School of Medicine
8. Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article
9. Novus Scientific and Singapore Association of Plastic Surgeons (SAPS) Host the Inaugural Event of SOFTISSUE - The Issue of Soft Tissue, Featuring James J. Chao, M.D., FACS, Professor of Plastic Surgery and Orthopedic Surgery, University of Califor
10. Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
11. Kenneth Alo, M.D., Joins Ascendant Neuro as Director of Neuromodulation and Clinical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016  The blood testing market ... dollars, according to Kalorama Information and The Freedonia Group ... and nucleic acid testing.  The healthcare research firm said ... in developing blood collection stations and in improving testing ... Kalorama Information,s report, Blood Testing Market in ...
(Date:4/28/2016)... , April 28, 2016 Dr. ... and Ste phen ... ArisGlobal®, a leading provider of cloud-based software solutions for life ... Pharmacovigilance team to bring a wealth of insight to a growing ... pharmacovigilance knowledge. George Phillips joined ArisGlobal in ...
(Date:4/28/2016)... 28, 2016  ValGenesis, Inc., the market ... (VLMS) today announced that a prominent world ... of chronic kidney failure has selected ValGenesis ... corporate validation process. The global medical device ... to manage their validation processes electronically. Upon ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... ... flexibility in repaying their loans, more information about their loan terms and accounts, ... outstanding student loan debt, including federal and private loans, has reached $1.3 trillion, ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... Kansas City, Missouri (PRWEB) , ... April 29, 2016 , ... ... Unlike traditional crutches which put pressure on the armpits, the M+D Crutch evenly distributes ... less strain on their wrists and hands when using the crutches than with other ...
(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a leading ... specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , A ... safety device secured by nasal surgeons onto the floor of the nasal passages, at ...
Breaking Medicine News(10 mins):